DNLI
Price
$12.86
Change
-$0.88 (-6.40%)
Updated
Apr 3, 02:35 PM (EDT)
Capitalization
2B
40 days until earnings call
OLMA
Price
$3.33
Change
-$0.01 (-0.30%)
Updated
Apr 2 closing price
Capitalization
227.55M
40 days until earnings call
Ad is loading...

DNLI vs OLMA

Header iconDNLI vs OLMA Comparison
Open Charts DNLI vs OLMABanner chart's image
Denali Therapeutics
Price$12.86
Change-$0.88 (-6.40%)
Volume$259
Capitalization2B
Olema Pharmaceuticals
Price$3.33
Change-$0.01 (-0.30%)
Volume$2.2M
Capitalization227.55M
DNLI vs OLMA Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. OLMA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and OLMA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (DNLI: $13.74 vs. OLMA: $3.33)
Brand notoriety: DNLI and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 298% vs. OLMA: 217%
Market capitalization -- DNLI: $2B vs. OLMA: $227.55M
DNLI [@Biotechnology] is valued at $2B. OLMA’s [@Biotechnology] market capitalization is $227.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, OLMA is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while OLMA’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 3 bearish.
  • OLMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than OLMA.

Price Growth

DNLI (@Biotechnology) experienced а -0.51% price change this week, while OLMA (@Biotechnology) price change was -19.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.32%. For the same industry, the average monthly price growth was -10.36%, and the average quarterly price growth was -14.47%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

OLMA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2B) has a higher market cap than OLMA($228M). DNLI YTD gains are higher at: -32.581 vs. OLMA (-42.882). OLMA has higher annual earnings (EBITDA): -135.54M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. OLMA (215M). OLMA has less debt than DNLI: OLMA (1.7M) vs DNLI (48.7M). DNLI (0) and OLMA (0) have equivalent revenues.
DNLIOLMADNLI / OLMA
Capitalization2B228M875%
EBITDA-492.89M-135.54M364%
Gain YTD-32.581-42.88276%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M215M387%
Total Debt48.7M1.7M2,866%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIOLMA
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEKX12.630.11
+0.88%
Baillie Gifford International Growth K
GSXCX24.92N/A
N/A
abrdn US Small Cap Equity C
CDDRX34.31N/A
N/A
Columbia Dividend Income Inst2
VMCRX5.41N/A
N/A
Voya MidCap Opportunities Port R6
NEXIX28.94N/A
N/A
Shelton Sustainable Equity Institutional

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+11.80%
BEAM - DNLI
57%
Loosely correlated
+4.79%
ARWR - DNLI
56%
Loosely correlated
+3.97%
NTLA - DNLI
55%
Loosely correlated
+9.69%
RCKT - DNLI
54%
Loosely correlated
+8.43%
RGNX - DNLI
53%
Loosely correlated
+4.29%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-0.30%
RCKT - OLMA
47%
Loosely correlated
+8.43%
DNLI - OLMA
46%
Loosely correlated
+11.80%
AGIO - OLMA
45%
Loosely correlated
+3.80%
CRNX - OLMA
44%
Loosely correlated
+2.51%
IDYA - OLMA
44%
Loosely correlated
+10.70%
More